Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CASC4 anticorps (C-Term)

CASC4 Reactivité: Humain, Souris WB, EIA Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN951049
  • Antigène Voir toutes CASC4 Anticorps
    CASC4 (Cancer Susceptibility Candidate 4 (CASC4))
    Épitope
    • 8
    • 8
    • 7
    • 1
    • 1
    • 1
    AA 343-373, C-Term
    Reactivité
    • 18
    • 10
    • 2
    • 2
    • 1
    • 1
    • 1
    Humain, Souris
    Hôte
    • 18
    Lapin
    Clonalité
    • 18
    Polyclonal
    Conjugué
    • 8
    • 2
    • 2
    • 2
    • 2
    • 2
    Cet anticorp CASC4 est non-conjugé
    Application
    • 18
    • 14
    • 12
    • 2
    • 1
    Western Blotting (WB), Enzyme Immunoassay (EIA)
    Specificité
    This antibody reacts to CASC4.
    Réactivité croisée (Details)
    Species reactivity (tested):Human and Mouse.
    Purification
    Affinity chromatography on Protein A
    Immunogène
    KLH conjugated synthetic peptide between 343-373 amino acids from the C-terminal region of human CASC4
    Isotype
    Ig Fraction
    Top Product
    Discover our top product CASC4 Anticorps primaire
  • Indications d'application
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    0.25 mg/mL
    Buffer
    PBS, 0.09 % (W/V) sodium azide
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Conseil sur la manipulation
    Avoid repeated freezing and thawing.
    Stock
    4 °C/-20 °C
    Stockage commentaire
    Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
  • Antigène
    CASC4 (Cancer Susceptibility Candidate 4 (CASC4))
    Autre désignation
    CASC4 (CASC4 Produits)
    Sujet
    The increased expression level of this gene is associated with HER-2/neu proto-oncogene overexpression. Amplification and resulting overexpression of this proto-oncogene are found in approximately 30 % of human breast and 20 % of human ovarian cancers. Further characterization of the product of this gene may yield insight into the fundamental biology and pathogenetic effects of HER-2/neu overexpression in human breast and ovarian cancer cells. Alternatively spliced variants encoding different isoforms have been identified for this gene.Synonyms: Cancer susceptibility candidate gene 4 protein
    Poids moléculaire
    48864 Da
    ID gène
    113201
    NCBI Accession
    NP_612432
Vous êtes ici:
Support technique